Sky Century Investment (SKYI) Cash from Operations (2012 - 2026)
Sky Century Investment (SKYI) posted quarterly Cash from Operations of 59238.0 for Q2 2026, down 198.53% year-over-year from 60120.0 in Q2 2025, and down 2813.61% quarter-over-quarter from 2183.0 in Q1 2026.
Sky Century Investment (SKYI) Cash from Operations (2012 - 2026) Analysis & Trends
Sky Century Investment (SKYI) has reported Cash from Operations for 6 consecutive years, with 59238.0 the latest figure, recorded in Q2 2026.
- In Q2 2026, Cash from Operations fell 198.53% year-over-year to 59238.0; the TTM figure through May 2026 stood at 56700.0 (down 201.42% YoY), while the FY2025 annual figure was 46481.0, up 9377.64% from the prior year.
- Cash from Operations retreated to 59238.0 in Q2 2026 per SKYI's latest filing, from 2183.0 in the prior quarter.
- Across five years, Cash from Operations topped out at 60120.0 in Q2 2025 and bottomed at 59238.0 in Q2 2026.
- Historically, Cash from Operations has averaged 1728.5 across 3 years, with a median of 6051.5 in 2024.
- Annual changes were most pronounced in 2025 — Cash from Operations soared 1120.19% — and 2026, when it slumped 198.53%.
- Sky Century Investment's Cash from Operations stood at 10827.0 in 2024, then surged by 42.64% to 6210.0 in 2025, then slumped by 853.91% to 59238.0 in 2026.
- Business Quant data shows SKYI's Cash from Operations at 59238.0 in Q2 2026, 2183.0 in Q1 2026, and 6210.0 in Q4 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Ops. (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 44.51 Bn | 43.55 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 43.52 Bn | 39.86 Bn | 2.15 Bn | 411.00 Mn |
| 3 | Zoetis | 32.43 Bn | 30.75 Bn | 1.05 Bn | 655.00 Mn |
| 4 | Takeda Pharmaceutical | 28.63 Bn | 22.83 Bn | 5.10 Bn | 800.69 Mn |
| 5 | United Therapeutics | 21.87 Bn | 19.21 Bn | 683.80 Mn | 313.60 Mn |
| 6 | Viatris | 18.98 Bn | 18.09 Bn | 1.46 Bn | 381.80 Mn |
| 7 | Neurocrine Biosciences | 15.43 Bn | 15.04 Bn | 935.80 Mn | 136.40 Mn |
| 8 | Elanco Animal Health | 12.02 Bn | 11.49 Bn | 798.00 Mn | 277.00 Mn |
| 9 | Dr Reddys Laboratories | 10.14 Bn | 9.98 Bn | - | - |
| 10 | Sky Century Investment | 393,547.71 | 393,283.71 | 26,045.00 | -59,238.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| May 31, 2026 | -59,238.00 |
| May 31, 2026 | -59,238.00 |
| Feb 28, 2026 | 2,183.00 |
| Feb 28, 2026 | 2,183.00 |
| Nov 30, 2025 | -6,210.00 |
| Nov 30, 2025 | -6,210.00 |
| Aug 31, 2025 | 6,565.00 |
| Aug 31, 2025 | 6,565.00 |
| May 31, 2025 | 60,120.00 |
| May 31, 2025 | 60,120.00 |
| Feb 28, 2025 | -9,377.00 |
| Feb 28, 2025 | -9,377.00 |
| Nov 30, 2024 | -10,827.00 |
| Nov 30, 2024 | -10,827.00 |
| Aug 31, 2024 | 15,990.00 |
| Aug 31, 2024 | 15,990.00 |
| May 31, 2024 | -5,893.00 |
| May 31, 2024 | -5,893.00 |
| Feb 29, 2024 | -10,598.00 |
| Feb 29, 2024 | -10,598.00 |